Precision BioSciences, Inc. (DTIL) vs ProQR Therapeutics N.V. (PRQR)
A side-by-side comparison of Precision BioSciences, Inc. and ProQR Therapeutics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DTIL
Precision BioSciences, Inc.
$6.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PRQR
ProQR Therapeutics N.V.
$1.66HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — DTIL vs PRQR
growth of $100 · dividends reinvested · last 8yDTIL -98.8% (-42.4%/yr)PRQR -88.9% (-24.0%/yr)PRQR compounded faster over this window
Log scale — wide-divergence pair
DTIL PRQR
DTIL vs PRQR: by the numbers
- •PRQR is the larger company ($174M vs $171M market cap).
- •Both run net losses; DTIL's is the smaller (-117.04% vs -229.20% net margin).
- •PRQR grew revenue faster over the past five years (94.34% vs 7.13% CAGR).
Metrics side by side
Valuation
| Metric | DTIL | PRQR |
|---|---|---|
| P/S ratio | 3.80 | 8.11 |
| P/B ratio | 3.78 | 1.92 |
Profitability
| Metric | DTIL | PRQR |
|---|---|---|
| Gross margin | 100.00% | 83.01% |
| Operating margin | -152.19% | -275.91% |
| Net margin | -117.04% | -229.20% |
| ROE | -116.42% | -54.27% |
| ROIC | -30.23% | -42.61% |
Growth (annualized)
| Metric | DTIL | PRQR |
|---|---|---|
| Revenue CAGR (5Y) | 7.13% | 94.34% |
| Total return CAGR (5Y) | -54.84% | -26.23% |
Frequently asked
- Which has grown faster, DTIL or PRQR?
- Over the past five years, PRQR grew revenue faster — DTIL at a 7.13% CAGR versus PRQR at 94.34%.
- How have DTIL and PRQR total returns compared?
- Over the past 5 years, DTIL delivered -54.84% and PRQR delivered -26.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Precision BioSciences ROEProQR Therapeutics ROEPrecision BioSciences operating marginProQR Therapeutics operating marginPrecision BioSciences revenue growthProQR Therapeutics revenue growthPrecision BioSciences free cash flowProQR Therapeutics free cash flow
Precision BioSciences & ProQR Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.